Filing Details
- Accession Number:
- 0001415889-24-007516
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-11 16:43:10
- Reporting Period:
- 2024-03-07
- Accepted Time:
- 2024-03-11 16:43:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1649989 | Outlook Therapeutics Inc. | OTLK | Biological Products, (No Disgnostic Substances) (2836) | 383982704 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1760511 | Jeff Evanson | C/O Outlook Therapeutics, Inc. 485 Route 1 South, Bldg F, Suite 320 Iselin NJ 08830 | Chief Commercial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-03-07 | 62,484 | $0.42 | 808,459 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.4044 to $0.42 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
